Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Susan Sencer"'
Autor:
Susan Sencer, Deanna Mitchell, Jessica Foley, Randal K. Wada, Joseph Junewick, Jeffrey P. Bond, Debra Pankiewicz, William Roberts, Monique Quinn, Jawhar Rawwas, William S. Ferguson, Javier Oesterheld, Giselle Saulnier Sholler, Jacqueline M. Kraveka, Valerie I. Brown, Kathleen A. Neville, Don Eslin, Francis Eshun, Genevieve Bergendahl, Peter E. Zage, Maria Rich, Nehal Parikh
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
Scientific reports, vol 8, iss 1
Sholler, Giselle L Saulnier; Ferguson, William; Bergendahl, Genevieve; Bond, Jeffrey P; Neville, Kathleen; Eslin, Don; et al.(2018). Maintenance DFMO Increases Survival in High Risk Neuroblastoma. SCIENTIFIC REPORTS, 8(1), 14445. doi: 10.1038/s41598-018-32659-w. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/4z74d9zw
Scientific reports, vol 8, iss 1
Sholler, Giselle L Saulnier; Ferguson, William; Bergendahl, Genevieve; Bond, Jeffrey P; Neville, Kathleen; Eslin, Don; et al.(2018). Maintenance DFMO Increases Survival in High Risk Neuroblastoma. SCIENTIFIC REPORTS, 8(1), 14445. doi: 10.1038/s41598-018-32659-w. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/4z74d9zw
High risk neuroblastoma (HRNB) accounts for 15% of all pediatric cancer deaths. Despite aggressive therapy approximately half of patients will relapse, typically with only transient responses to second-line therapy. This study evaluated the ornithine
Publikováno v:
Pediatric bloodcancerREFERENCES. 67(4)
Autor:
Susan Sencer, Shari Baldinger, D. Ashley Hill, Louis P. Dehner, Yoav Messinger, Kris Ann P. Schultz, Anne K. Harris
Publikováno v:
Familial Cancer. 15:105-110
Germline DICER1 mutations have been described in individuals with pleuropulmonary blastoma (PPB), ovarian Sertoli-Leydig cell tumor (SLCT), sarcomas, multinodular goiter, thyroid carcinoma, cystic nephroma and other neoplastic conditions. Early resul
Autor:
Sunita Vohra, Courtney Spelliscy, Paul E. Grundy, Leka Sivakumar, Susan Sencer, Denise Adams, Anne Leis
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-Based Complementary and Alternative Medicine, Vol 2013 (2013)
Evidence-Based Complementary and Alternative Medicine, Vol 2013 (2013)
Background. Use of complementary and alternative medicine (CAM) by children with cancer is high; however, pediatric best cases are rare.Objectives. To investigate whether best cases exist in pediatric oncology using a three-phase approach and to comp
Publikováno v:
Journal of Pediatric Oncology Nursing. 26:7-15
The objective of this survey is to determine the frequency, reasons, and factors influencing use of complementary and alternative medicine (CAM) in general and specialty pediatrics within the same geographic area. Of the 281 surveys completed, CAM us
Autor:
Susan Sencer, Kara M. Kelly
Publikováno v:
Pediatric Clinics of North America. 54:1043-1060
Evidence on the science of complementary and alternative medicine (CAM) in children with cancer is slowly evolving. Most parents of children with cancer want their children to receive state-of-the-art therapy, which generally includes chemotherapy, r
Publikováno v:
Pediatric Blood & Cancer. 44:167-173
*INTRODUCTIONPediatric ovarian tumors are an uncommon but impor-tant form of childhood cancer. Ovarian tumors are themost frequent neoplasms of the female genital tract inchildhood [1] and are generally considered to accountfor approximately 1% of al
Autor:
Kaci Osenga, Joanne Wolfe, Jill Dreyfus, Stefan J. Friedrichsdorf, Andrea Postier, Susan Sencer
Publikováno v:
Journal of palliative medicine. 18(2)
Nearly 2000 children die due to a malignancy in the United States annually. Emerging data suggest that home is the desired location of care for children with cancer at end of life. However, one obstacle to enrollment in a pediatric palliative care (P
Autor:
Janice, Post-White, Susan, Sencer
Publikováno v:
Pediatric bloodcancer. 61(4)
Publikováno v:
Otolaryngology–Head and Neck Surgery. 145